Follow
Professor Rod Hicks
Professor Rod Hicks
Department of Medicine, St Vincent's Hospital, the University of Melbourne and Department of
Verified email at mtic.net.au - Homepage
Title
Cited by
Cited by
Year
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ...
Journal of clinical oncology 25 (5), 571-578, 2007
16652007
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
SF Barrington, NG Mikhaeel, L Kostakoglu, M Meignan, M Hutchings, ...
Journal of clinical oncology 32 (27), 3048, 2014
16162014
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised …
MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, ...
The Lancet 395 (10231), 1208-1216, 2020
13032020
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ...
The Lancet Oncology 19 (6), 825-833, 2018
9392018
Delivering affordable cancer care in high-income countries
R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ...
The lancet oncology 12 (10), 933-980, 2011
7922011
Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer …
D Rischin, RJ Hicks, R Fisher, D Binns, J Corry, S Porceddu, LJ Peters
Journal of Clinical Oncology 24 (13), 2098-2104, 2006
5872006
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non–small-cell …
MP Mac Manus, RJ Hicks, JP Matthews, A McKenzie, D Rischin, ...
Journal of Clinical Oncology 21 (7), 1285-1292, 2003
5232003
Evaluation of circulating tumor cells and circulating tumor DNA in non–small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab …
EA Punnoose, S Atwal, W Liu, R Raja, BM Fine, BGM Hughes, RJ Hicks, ...
Clinical Cancer Research 18 (8), 2391-2401, 2012
5022012
Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation
MS Hofman, WFE Lau, RJ Hicks
Radiographics 35 (2), 500-516, 2015
4862015
Ibrutinib plus venetoclax for the treatment of mantle-cell lymphoma
CS Tam, MA Anderson, C Pott, R Agarwal, S Handunnetti, RJ Hicks, ...
New England journal of medicine 378 (13), 1211-1223, 2018
4092018
MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome
RP Carne, TJ O'brien, CJ Kilpatrick, LR MacGregor, RJ Hicks, MA Murphy, ...
Brain 127 (10), 2276-2285, 2004
3882004
90Y-edotreotide for metastatic carcinoid refractory to octreotide
DL Bushnell Jr, TM O'Dorisio, MS O'Dorisio, Y Menda, RJ Hicks, ...
Journal of Clinical Oncology 28 (10), 1652, 2010
3792010
ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine and hybrid imaging
A Sundin, R Arnold, E Baudin, JB Cwikla, B Eriksson, S Fanti, N Fazio, ...
Neuroendocrinology 105 (3), 212-244, 2017
3772017
High rate of detection of unsuspected distant metastases by PET in apparent Stage III non–small-cell lung cancer: implications for radical radiation therapy
MP Mac Manus, RJ Hicks, JP Matthews, A Hogg, AF McKenzie, A Wirth, ...
International Journal of Radiation Oncology* Biology* Physics 50 (2), 287-293, 2001
3682001
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ...
Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015
3382015
Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes
J Violet, P Jackson, J Ferdinandus, S Sandhu, T Akhurst, A Iravani, ...
Journal of Nuclear Medicine 60 (4), 517-523, 2019
3292019
UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas
SQ Wong, K Waldeck, IA Vergara, J Schröder, J Madore, JS Wilmott, ...
Cancer research 75 (24), 5228-5234, 2015
3262015
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)
C Kratochwil, WP Fendler, M Eiber, R Baum, MF Bozkurt, J Czernin, ...
European journal of nuclear medicine and molecular imaging 46, 2536-2544, 2019
3222019
Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls
MS Hofman, RJ Hicks, T Maurer, M Eiber
Radiographics 38 (1), 200-217, 2018
3122018
18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non–small cell lung cancer
RJ Hicks, V Kalff, MP MacManus, RE Ware, A Hogg, AF McKenzie, ...
Journal of Nuclear Medicine 42 (11), 1596-1604, 2001
3022001
The system can't perform the operation now. Try again later.
Articles 1–20